Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v4-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2022-12-05 | 2022-12-05 |
Drug Identification Number | 02395150 | 02395150 |
Brand name | 0.9% SODIUM CHLORIDE INJECTION | 0.9% SODIUM CHLORIDE INJECTION |
Common or Proper name | 0.9% SODIUM CHLORIDE INJECTION | 0.9% SODIUM CHLORIDE INJECTION |
Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
Ingredients | SODIUM CHLORIDE | SODIUM CHLORIDE |
Strength(s) | 900MG | 900MG |
Dosage form(s) | SOLUTION SOLUTION | SOLUTION SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000mL | 1000mL |
ATC code | B05XA | B05XA |
ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2022-10-01 | 2022-10-01 |
Estimated end date | Unknown | Unknown |
Actual end date | 2022-11-30 | 2022-11-30 |
Shortage status | Resolved | Resolved |
Tier 3 Status | No | No |
Company comments | Fresenius Kabi Canada regrets to advise that due to increased demand, our Sodium Chloride 0.9% Injection freeflex® Bag 1000 mL will be placed on allocation effective October 1, 2022. Customers will be allocated 200% of historical monthly demand. | Fresenius Kabi Canada regrets to advise that due to increased demand, our Sodium Chloride 0.9% Injection freeflex® Bag 1000 mL will be placed on allocation effective October 1, 2022. Customers will be allocated 200% of historical monthly demand. |
Health Canada comments |